Several side effects of anabolic-androgenic steroid (AAS) administration associated with training are reported in the biomechanical properties of the calcaneal tendon (CT) of rats. Thus, the aim of the present study is to evaluate the effects of the detraining and discontinuation of AAS administration on the CT morphology of rats submitted to exercise in water. Animals were divided into two groups (20/group): (1) Immediately after training (IA), and (2) Six weeks of detraining and AAS discontinuation (6W). The IA group included four subgroups: Sedentary (S), Trained (T), Sedentary with AAS administration (SAAS), and trained with AAS administration (TAAS). The 6W group included four subgroups: Sedentary (6W-S), six weeks of detrained (6W-T), six weeks of sedentary with AAS discontinuation (6W-SAAS), and six weeks of detrained with AAS discontinuation (6W-TAAS). Data show significant reduction in adipose cells volume density (Vv%) in the distal CT in 6W-TAAS group, indicating that training can exert a positive effect on the tendon. The 6W-SAAS group exhibited increased adipose cells Vv% in the distal region, compared with the W6-S and W6-T groups. A decrease in tendon proper cells Vv% and in peritendinous sheath cells Vv% of proximal and distal regions was also observed. In 6W-TAAS group showed increase in adipose cells, blood vessels, peritendinous sheath cells, and tendon proper cells Vv% in the distal region of the CT. The vertical jumps in water were not able to protect CT regions from the negative effects of AAS discontinuation for six weeks. However, after detraining and AAS discontinuation, many protective factors of the mechanical load in the long-term could be observed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739234 | PMC |
| http://dx.doi.org/10.3390/jfmk4010001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Coronary Microvascular Dysfunction Years After Cessation of Anabolic Androgenic Steroid Use.
JAMA Netw Open
December 2024
Department of Nephrology and Endocrinology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Importance: Long-term use of anabolic androgenic steroids (AASs) is associated with a high risk of left ventricular hypertrophy, heart failure with reduced systolic function, and early sudden death, with the mechanism of progression being understudied. Early and persistent impaired myocardial microcirculation could be of clinical importance and a potential underlying mechanism of frequent and early cardiac disease among individuals with AAS use and a future potential target for intervention.
Objective: To investigate coronary microcirculation by measuring myocardial flow reserve (MFR) in men with current and former AAS use compared with controls with no prior AAS use, using cardiac rubidium 82 (82Rb) positron emission tomography/computed tomography (PET/CT).
Association of Anabolic Steroid Use With Hypertension and Cardiomyopathy: A Case Study.
Cureus
October 2024
Internal Medicine, Sound Physicians/Montefiore Nyack Hospital, Nyack, USA.
Article Synopsis
- * A case study discusses a 46-year-old man who experienced complications like swelling, bruising, and shortness of breath due to AAS use, revealing underlying issues like high blood pressure and heart failure.
- * The case highlights the importance of screening for heart and vascular health in individuals using anabolic steroids, as they may not exhibit clear symptoms of underlying heart conditions.
A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
Osteoarthr Cartil Open
December 2024
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Background: Pain associated with osteoarthritis (OA) is frequently disabling; treatments are often ineffective or intolerable. Fasinumab selectively inhibits nerve-growth factor and has shown efficacy for the management of OA pain.
Methods: In this randomized, double-blind, phase III safety study, patients with moderate-to-severe OA pain and history of inadequate pain relief received placebo or fasinumab (at 1, 3, 6, and 9 mg every 4 weeks [Q4W] and 1 and 6 mg every 8 weeks [Q8W] for 52 weeks).
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv
November 2024
Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University Medical Center, Stanford University, Stanford, CA.
Article Synopsis
- Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have limited treatment options, prompting the investigation of magrolimab (M) combined with rituximab (R), and M combined with gemcitabine-oxaliplatin (M+R-GemOx) for long-term disease control.
- In a study involving 132 patients, M+R achieved an objective response rate (ORR) of 24%, while M+R-GemOx showed a higher ORR of 52%, with notable complete response (CR) rates of 12% and 39%, respectively.
- Both treatments were generally well tolerated, though common side effects included fatigue and anemia, with
Persistent physiological benefits from doping? Ethical implications for sports integrity.
J Appl Physiol (1985)
October 2024
International Federation of Sports Medicine (FIMS), Lausanne, Switzerland.
The effects of some widely abused doping substances such as anabolic androgenic steroids (AAS) on performance are well documented, particularly in the short term, and the use of these substances is banned by various sporting authorities, with athletes sanctioned from competing for up to 4 years. However, controversy exists on whether residual physiological effects of some doping practices could persist even years after discontinuation, granting unfair advantages to athletes long after sanctions have been served. Particularly, in support of the so-called muscle memory theory, growing evidence in both animals and humans suggests that AAS administration could exert long-term effects at the muscle level, notably a higher number of myonuclei.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!